| 摘要 |
<p>A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.</p> |
| 申请人 |
UCB PHARMA S.A.;ALLEN, DANIEL, REES;BUCKLEY, GEORGE, MARTIN;BUERLI, ROLAND;DAVENPORT, RICHARD, JOHN;KINSELLA, NATASHA;LOCK, CHRISTOPHER, JAMES;LOWE, CHRISTOPHER;MACK, STEPHEN, ROBERT;PITT, WILLIAM, ROSS;RATCLIFFE, ANDREW, JAMES;RICHARD, MARIANNA, DILANI;SABIN, VERITY, MARGARET;SHARPE, ANDREW;TAIT, LAURA, JANE;WARRELOW, GRAHAM, JOHN;WILLIAMS, SOPHIE, CAROLINE |
发明人 |
ALLEN, DANIEL, REES;BUCKLEY, GEORGE, MARTIN;BUERLI, ROLAND;DAVENPORT, RICHARD, JOHN;KINSELLA, NATASHA;LOCK, CHRISTOPHER, JAMES;LOWE, CHRISTOPHER;MACK, STEPHEN, ROBERT;PITT, WILLIAM, ROSS;RATCLIFFE, ANDREW, JAMES;RICHARD, MARIANNA, DILANI;SABIN, VERITY, MARGARET;SHARPE, ANDREW;TAIT, LAURA, JANE;WARRELOW, GRAHAM, JOHN;WILLIAMS, SOPHIE, CAROLINE |
